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Pulmonary cryptococcosis and cryptococcal osteomyelitis mimicking
primary and metastatic lung cancer in 18F-FDG PET/CT
Figure 1. Computed tomography of the lung: (a) CT demonstrates multiple lesions in the apex of the right lung, and some had cavities at the time of diagnosis; (b) follow-up
CT showed progressive regression of the lesions and no relapsed infection after 5 months.
Figure 2. MRI of the spine at diagnosis, showing lesions in the thoracic vertebrae (T9 level) and sacral vertebrae (S1 level), which were suspicious for inﬂammatory changes
and osteomyelitis (red arrow).
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Medical Imagery / International Journal of Infectious Diseases 18 (2014) 101–103102Figure 3. PET/CT showing nodular lesions in the lung, T9 thoracic vertebrae, and sacral vertebrae, with high-level glucose uptake. The maximum standard uptake value of lung
was 6.87 and of bone was 16.39.Figure 4. Tissue biopsy from the T9 thoracic vertebrae showing granulomatous
inﬂammation with numerous oval and clear microorganisms, with birefringence
(red arrow) in the macrophages. Silver stain demonstrated a positive reaction to
these microorganisms. There was no evidence of malignancy (400).A 34-year-old woman was admitted to our hospital with a
history of 2.5 months of low fever and 3 weeks of back pain. Ten
months before admission she was diagnosed with systemic lupus
erythematosus and started to receive corticosteroids 40 mg daily.
At the time of admission, she had been taking hydroxychloroquine
100 mg twice a day for 3 months and the current dosage of
corticosteroids was 10 mg daily. The results of laboratory tests
including blood culture were negative. A chest computed
tomography (CT) scan showed lesions in the right lung
(Figure 1). Magnetic resonance imaging (MRI) revealed lesions
in the T9 thoracic vertebrae and sacral vertebrae (Figure 2). 18F-
ﬂuorodeoxyglucose positron emission tomography/CT (18F-FDG
PET/CT) examination showed the maximum standard uptake value
of lung was 6.87 and of bone was 16.39 (Figure 3). A diagnosis of
lung cancer with bone metastases was suggested. After performing
a thoracic vertebrae biopsy, the ﬁnal diagnosis of pulmonary
cryptococcosis and cryptococcal osteomyelitis was conﬁrmed
(Figure 4). Puncture culture conﬁrmed the subtype was Cryptococ-
cus neoformans. A 4-week induction therapy with amphotericin B
and 5-ﬂucytosine was then started, which was followed by oral
ﬂuconazole (400 mg daily for 8 weeks, then 200 mg daily for 6
months).1 At the beginning of induction therapy, hydroxychlor-
oquine was discontinued and corticosteroids were still given at
10 mg daily. Follow-up lung CT showed progressive regression of
the lesions and no relapsed infection (Figure 1). In summary,
cryptococcosis mimics cancer on 18F-FDG PET/CT.2,3 Tissue
conﬁrmation should be considered, especially for immunosup-
pressed patients.
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